Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Ruboxistaurin> ?p ?o. }
Showing items 1 to 43 of
43
with 100 items per page.
- Ruboxistaurin abstract "Ruboxistaurin (proposed brand name Arxxant) is an investigational drug for diabetic peripheral retinopathy. It is being investigated by Eli Lilly and Company.On February 2006, Lilly submitted a New Drug Application for ruboxistaurin, and on August 18, 2006, Lilly received an "approvable" letter from the United States Food and Drug Administration for ruboxistaurin, with a request for an additional clinical trial, which would take 5 years to complete.".
- Ruboxistaurin atcPrefix "none".
- Ruboxistaurin casNumber "169939-94-0".
- Ruboxistaurin fdaUniiCode "721809WQCP".
- Ruboxistaurin iupacName "(9S)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-di(metheno)dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20-dione".
- Ruboxistaurin pubchem "153999".
- Ruboxistaurin thumbnail Ruboxistaurin.svg?width=300.
- Ruboxistaurin wikiPageExternalLink pipeline.cfm.
- Ruboxistaurin wikiPageID "15770520".
- Ruboxistaurin wikiPageRevisionID "592961764".
- Ruboxistaurin atcPrefix "none".
- Ruboxistaurin c "28".
- Ruboxistaurin casNumber "169939".
- Ruboxistaurin chembl "91829".
- Ruboxistaurin chemspiderid "135727".
- Ruboxistaurin h "28".
- Ruboxistaurin hasPhotoCollection Ruboxistaurin.
- Ruboxistaurin iupacName "-9".
- Ruboxistaurin molecularWeight "468.546".
- Ruboxistaurin n "4".
- Ruboxistaurin o "3".
- Ruboxistaurin pubchem "153999".
- Ruboxistaurin stdinchi "1".
- Ruboxistaurin stdinchikey "ZCBUQCWBWNUWSU-SFHVURJKSA-N".
- Ruboxistaurin unii "721809".
- Ruboxistaurin verifiedfields "changed".
- Ruboxistaurin verifiedrevid "477855864".
- Ruboxistaurin subject Category:Eli_Lilly_and_Company.
- Ruboxistaurin subject Category:Indoles.
- Ruboxistaurin subject Category:Maleimides.
- Ruboxistaurin type Drug.
- Ruboxistaurin type DrugProduct.
- Ruboxistaurin type FunctionalSubstance.
- Ruboxistaurin comment "Ruboxistaurin (proposed brand name Arxxant) is an investigational drug for diabetic peripheral retinopathy. It is being investigated by Eli Lilly and Company.On February 2006, Lilly submitted a New Drug Application for ruboxistaurin, and on August 18, 2006, Lilly received an "approvable" letter from the United States Food and Drug Administration for ruboxistaurin, with a request for an additional clinical trial, which would take 5 years to complete.".
- Ruboxistaurin label "Ruboxistaurin".
- Ruboxistaurin label "ルボキシスタウリン".
- Ruboxistaurin sameAs ルボキシスタウリン.
- Ruboxistaurin sameAs m.03ns_9t.
- Ruboxistaurin sameAs Q7376181.
- Ruboxistaurin sameAs Q7376181.
- Ruboxistaurin wasDerivedFrom Ruboxistaurin?oldid=592961764.
- Ruboxistaurin depiction Ruboxistaurin.svg.
- Ruboxistaurin isPrimaryTopicOf Ruboxistaurin.
